Carbinoxamine
Back to searchMolecule Structure
Scientific Name
Carbinoxamine
Description of the Drug
Carbinoxamine is a first generation antihistamine used to treat allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, allergic reactions, and mild allergic reactions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00748
http://www.drugbank.ca/drugs/DB00748
Brand Name(s)
Not Available
Company Owner(s)
Vintage Pharmaceuticals, Invagen Pharmaceuticals Inc, Mission Pharmacal Co, Mikart Llc, Ortho Mcneil Pharmaceutical Inc, Mcneil Pharmaceutical Co Div Mcneilab Inc, Cypress Pharmaceutical Inc, Strides Pharma Global Pte Ltd, Aytu Bioscience Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5070 | |
| PharmGKB | PA164746898 | |
| Human Metabolome Database | HMDB0014886 | |
| DrugBank | DB00748 | |
| PubChem: Thomson Pharma | 16888880 | |
| PubChem | 2564 | |
| LINCS | LSM-1435 | |
| Nikkaji | J6.006B | J7.994D |
| BindingDB | 81464 | |
| EPA CompTox Dashboard | DTXSID4022737 | |
| DrugCentral | 499 | |
| ChemicalBook | CB4875334 | |
| Guide to Pharmacology | 7139 | |
| rxnorm | CARBINOXAMINE | CARBINOXAMINE MALEATE |
| KEGG Ligand | C06871 | |
| ChEBI | 3398 |
